Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Big Data

Sec. Medicine and Public Health

Volume 8 - 2025 | doi: 10.3389/fdata.2025.1626715

Comparison of Random Survival Forest to traditional Cox regression in predicting cancer-specific survival of breast carcinosarcoma

Provisionally accepted
Yalong  ZhangYalong ZhangYajuan  RenYajuan Ren*
  • Longhua Hospital affiliated to Shanghai University of TCM, shanghai, China

The final, formatted version of the article will be published soon.

This study compares the predictive performance of Random Survival Forest (RSF) and traditional Cox regression for cancer-specific survival (CSS) in breast carcinosarcoma (BS) patients.BS patients were identified from the SEER database and randomly divided into training (70%) and validation (30%) cohorts. Predictor variables were selected using univariable and multivariable Cox proportional hazards analyses. Nomogram, RSF, and Cox proportional hazards models were developed and evaluated using the area under the receiver operating characteristic curve (AUC), decision curve analysis, and calibration curves. Model interpretability was evaluated using time-varying feature importance, partial dependence plots, SurvSHAP(t), and SurvLIME analyses.variables were significantly associated with CSS: age, median household income, year of diagnosis, histological subtype, surgical treatment, radiation therapy, tumor grade, summary stage, and tumor size. The RSF model demonstrated superior discriminative ability, with higher AUC values at 1, 3, and 5 years compared to the Cox model. Decision curve analysis confirmed greater clinical utility for the RSF model. Summary stage, tumor size, age, tumor grade, and surgical treatment were identified as the most influential predictors.The RSF model outperformed Cox regression in predicting CSS for BS patients, offering superior accuracy and interpretable, personalized survival predictions.

Keywords: Random survival forest, machine learning, Cox regression, Cancer-specific survival, Breast carcinosarcoma, SurvLIME, SurvSHAP

Received: 14 May 2025; Accepted: 02 Sep 2025.

Copyright: © 2025 Zhang and Ren. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yajuan Ren, Longhua Hospital affiliated to Shanghai University of TCM, shanghai, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.